Demand of Ayurvedic medicines has increased abroad due to Corona crisis. India’s herb exports to all countries of Asia along with America and Europe have increased. More than 300 crore herbs are exported annually from Indore and nearby cities of Madhya Pradesh. Annual exports are estimated to reach double due to the Corona epidemic. Not only this, the world’s confident wavering from China has also played a big role in this and a big market is expected to shift towards India.
Earlier, there was also a demand for Chinese medicines abroad, but now a large part of it is expected to come to India. About 150 Ayurvedic processing units are operating in the Indore-Ujjain region. Out of these, more than 60 units are exporting drugs on a large scale.
In such a situation, when the experts of the world are talking about increasing immunity, the market of herbs is increasing. Exports are estimated to be up to Rs 50-60 crore every month after the lockdown. Store Market & Research of Europe has marked India’s herb exporters. In such a situation, it is expected that once the lockdown opens, the export figures will also increase rapidly. According to the herb processing industries, 10 drugs are being exported the most. Among them, Giloy and Tulsi are the most sought after.
Apart from this, demand has also increased in Ashwagandha, Amla, Gokharu, Kalmegh or Chirayata, Turmeric, Papaya seeds, Noni and Saunth. Chirality or Kalmegh has already been considered influential on influenza fever etc. It has also been used in China. Therefore, their demand is increasing rapidly. It is worth mentioning that in India too, there is a large scale preparation of Ayurvedic medicines. The Drug Controller of India has approved the use of four Ayurvedic medicines including Ashwagandha and another medicine named Ayush-64 in the treatment of corona.
